Ventricular remodeling phenotypes following intermittent levosimendan therapy in advanced heart failure

9 May 2026 (08:00 - 12:45)

Organised by:

Sign in to view the resources

About the speaker

Doctor Raquel Fernandes Da Silva

ACES Alentejo Central, Evora (Portugal)

6 More presentations in this session

Presentation thumbnail

Effects of CDR132L on cardiac structure and function in heart failure with preserved ejection fraction and left ventricular hypertrophy: the 8212-Preserved trial

Professor R. De Boer (Rotterdam, NL)

Presentation thumbnail

Left ventricular remodeling and fibrosis indices are strongly associated with soluble ST2 but not with NTproBNP in patients with HFrEF: a comparative analysis

Doctor A. Ntalianis (Athens, GR)

Presentation thumbnail

A parsimonious echocardiography-based model for long-term mortality risk stratification in heart failure with preserved ejection fraction

Doctor L. Mi (Beijing, CN)

Presentation thumbnail

The role of diastolic dysfunction in heart failure with reduced ejection fraction (HFrEF)

Professor E. Jones (Leuven, BE)

Presentation thumbnail

Right atrial stiffness index predicts mortality in pulmonary hypertension when standard atrial metrics fail

Doctor A. Pearlman (Melbourne, AU)

Access the full session

Session thumbnail

Echocardiographic evaluation of mechanisms in heart failure

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Session

Mechanical unloading in cardiogenic shock

Congress Presentation

Saline load induces acute changes in ventricular extracellular volume and mass in an early model of HF

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources